https://www.merit.com/wp-content/uploads/2018/09/Merit-Medical-Systems-Inc-logo-breastcancer.png 0 0 Merit Medical https://www.merit.com/wp-content/uploads/2018/09/Merit-Medical-Systems-Inc-logo-breastcancer.png Merit Medical2012-03-06 17:16:002015-08-06 15:08:06Merit Reaches Distribution Agreement for the Clo-SurPLUS P.A.D.™
Merit Medical Systems, Inc. has negotiated a long-term distribution agreement with Scion Cardio-Vascular to sell its Clo-SurPLUS P.A.D., a soft, non-woven topical pad that provides an optimal wound-healing environment with an effective antibacterial barrier. The pad is intended for the local management of bleeding wounds and to provide a barrier to bacterial penetration of the dressing. For Interventional Cardiologists and Radiologists with patients who are anti-coagulated or who have bleeding complications after interventional or diagnostic peripheral vascular procedures, the Clo-SurPLUS P.A.D. can effectively coagulate fully heparinized blood. The Clo-SurPLUS P.A.D. reduces hold time as well as time to ambulation.
The pad is versatile and can be placed around sites involving percutaneous catheters, tubes, and pins. The Clo-SurPLUS P.A.D. has demonstrated in-vitro antibacterial activity for up to 6 days. It is water soluble for easy and painless removal, which is more comfortable for the patient.
Sr. Product Manager
Merit Medical Systems, Inc.